Anirban Bhattacharya

Theramyt Novobiologics Pvt Ltd. develops novel biobetters, biosimilars and new biological entities. It focuses on the development of therapeutic monoclonal antibodies. The firm offers its products for oncology, rheumatoid arthritis, diabetes, and metabolic disorders. The company was founded by Sohang Chatterjee and Kavitha Iyer Rodrigues in 2013 and is headquartered in Bangalore, India.

Theramyt Novobiologics Pvt Ltd. develops novel biobetters, biosimilars and new biological entities. It focuses on the development of therapeutic monoclonal antibodies. The firm offers its products for oncology, rheumatoid arthritis, diabetes, and metabolic disorders. The company was founded by Sohang Chatterjee and Kavitha Iyer Rodrigues in 2013 and is headquartered in Bangalore, India.

Theramyt Novobiologics Pvt Ltd. develops novel biobetters, biosimilars and new biological entities. It focuses on the development of therapeutic monoclonal antibodies. The firm offers its products for oncology, rheumatoid arthritis, diabetes, and metabolic disorders. The company was founded by Sohang Chatterjee and Kavitha Iyer Rodrigues in 2013 and is headquartered in Bangalore, India.

Theramyt Novobiologics Pvt Ltd. develops novel biobetters, biosimilars and new biological entities. It focuses on the development of therapeutic monoclonal antibodies. The firm offers its products for oncology, rheumatoid arthritis, diabetes, and metabolic disorders. The company was founded by Sohang Chatterjee and Kavitha Iyer Rodrigues in 2013 and is headquartered in Bangalore, India.